199 related articles for article (PubMed ID: 14753389)
1. Smallpox vaccine: problems and prospects.
Poland GA; Neff JM
Immunol Allergy Clin North Am; 2003 Nov; 23(4):731-43. PubMed ID: 14753389
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
[TBL] [Abstract][Full Text] [Related]
3. Smallpox vaccination and adverse reactions. Guidance for clinicians.
Cono J; Casey CG; Bell DM;
MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
[TBL] [Abstract][Full Text] [Related]
4. Clinical guidance for smallpox vaccine use in a postevent vaccination program.
Petersen BW; Damon IK; Pertowski CA; Meaney-Delman D; Guarnizo JT; Beigi RH; Edwards KM; Fisher MC; Frey SE; Lynfield R; Willoughby RE
MMWR Recomm Rep; 2015 Feb; 64(RR-02):1-26. PubMed ID: 25695372
[TBL] [Abstract][Full Text] [Related]
5. Smallpox vaccination and bioterrorism with pox viruses.
Mayr A
Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):423-30. PubMed ID: 12818626
[TBL] [Abstract][Full Text] [Related]
6. An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies.
Wiser I; Balicer RD; Cohen D
Vaccine; 2007 Jan; 25(6):976-84. PubMed ID: 17074424
[TBL] [Abstract][Full Text] [Related]
7. Smallpox vaccines: Past, present, and future.
Parrino J; Graham BS
J Allergy Clin Immunol; 2006 Dec; 118(6):1320-6. PubMed ID: 17157663
[TBL] [Abstract][Full Text] [Related]
8. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice.
Nishiyama Y; Fujii T; Kanatani Y; Shinmura Y; Yokote H; Hashizume S
Vaccine; 2015 Nov; 33(45):6120-7. PubMed ID: 26455406
[TBL] [Abstract][Full Text] [Related]
9. Smallpox vaccines for biodefense: need and feasibility.
Artenstein AW; Grabenstein JD
Expert Rev Vaccines; 2008 Oct; 7(8):1225-37. PubMed ID: 18844596
[TBL] [Abstract][Full Text] [Related]
10. LC16m8: an attenuated smallpox vaccine.
Kenner J; Cameron F; Empig C; Jobes DV; Gurwith M
Vaccine; 2006 Nov; 24(47-48):7009-22. PubMed ID: 17052815
[TBL] [Abstract][Full Text] [Related]
11. New generation smallpox vaccines: a review of preclinical and clinical data.
Artenstein AW
Rev Med Virol; 2008; 18(4):217-31. PubMed ID: 18283712
[TBL] [Abstract][Full Text] [Related]
12. The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks.
Handley L; Buller RM; Frey SE; Bellone C; Parker S
Expert Rev Vaccines; 2009 Jul; 8(7):841-50. PubMed ID: 19538111
[TBL] [Abstract][Full Text] [Related]
13. Expected adverse events in a mass smallpox vaccination campaign.
Kemper AR; Davis MM; Freed GL
Eff Clin Pract; 2002; 5(2):84-90. PubMed ID: 11990216
[TBL] [Abstract][Full Text] [Related]
14. Smallpox: a review of clinical disease and vaccination.
Lofquist JM; Weimert NA; Hayney MS
Am J Health Syst Pharm; 2003 Apr; 60(8):749-56; quiz 757-8. PubMed ID: 12749161
[TBL] [Abstract][Full Text] [Related]
15. Vaccines for preventing smallpox.
Metzger W; Mordmueller BG
Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD004913. PubMed ID: 17636779
[TBL] [Abstract][Full Text] [Related]
16. Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
Meseda CA; Weir JP
Future Microbiol; 2010 Sep; 5(9):1367-82. PubMed ID: 20860482
[TBL] [Abstract][Full Text] [Related]
17. Vaccinia virus-induced smallpox postvaccinal encephalitis in case of blood-brain barrier damage.
Garcel A; Fauquette W; Dehouck MP; Crance JM; Favier AL
Vaccine; 2012 Feb; 30(7):1397-405. PubMed ID: 22227123
[TBL] [Abstract][Full Text] [Related]
18. TLR3 and TLR9 agonists improve postexposure vaccination efficacy of live smallpox vaccines.
Israely T; Melamed S; Achdout H; Erez N; Politi B; Waner T; Lustig S; Paran N
PLoS One; 2014; 9(10):e110545. PubMed ID: 25350003
[TBL] [Abstract][Full Text] [Related]
19. Smallpox: a potential agent of bioterrorism.
Whitley RJ
Antiviral Res; 2003 Jan; 57(1-2):7-12. PubMed ID: 12615298
[TBL] [Abstract][Full Text] [Related]
20. An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.
Morikawa S; Sakiyama T; Hasegawa H; Saijo M; Maeda A; Kurane I; Maeno G; Kimura J; Hirama C; Yoshida T; Asahi-Ozaki Y; Sata T; Kurata T; Kojima A
J Virol; 2005 Sep; 79(18):11873-91. PubMed ID: 16140764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
